Subscribe to our newsletter
-
Michelle is one of three Public Advisors to the Applied Research Collaboration (ARC KSS) Board. She sits on the KSS ARC Regional Forum & Co-Production Group and has an extensive background in both public and professional arenas.
Michelle holds a Bachelor of Laws, LLB; Executive Institute of Leadership and Management (ILM); qualified & specialised in Quality Assurance (CES); Change Management; Advocacy Services; Medical & Research Ethics; Equality & Diversity; Assets-Based Approaches and is a Kent Surrey and Sussex Health Leadership - Patient Leader.
A senior specialist advisor for Integrated Authoring Solutions offering a range of solution services within health, regulation, communication and management internationally. She headed up Independent Health Complaints in Kent.
Michelle has held non-executive director roles within various local, regional and international charities, including: Citizens Rights for Older People; Avante Care & Support; Chair of ASTI and Deputy Chair of a Research Ethics Committee.
She currently represents patients and citizens in a number of wide-ranging roles from NHS England and Improvement as a Patient and Public Voice (PPV) Expert Partner for the National Cancer Programme of Care Board, its Clinical Product Assurance Group & Genomics Test Evaluation Working Group. The Chief Nursing Officer for England’s, Strategic Plan for Research Delivery Board, Demand Signalling Oversight Group & Advisory Group. Michelle is a member of the national Patient and Participation Groups (PPGs) Champion & Peer Trainers Groups.
At a county level and the Clinical Commissioning Group (CCG), Michelle sat on the Clinical Professional & Primary Care Boards; Patient & Public Advisory Group; Cancer Alliance Collaborative Group(s). She currently sits on the Integrated Care System (ICS) Kent & Medway Care Record Communications & Engagement & Technical Reference Oversight Group(s); My Care Record Steering Group and is chair of My Care Record - Citizen Engagement Group. She is a member of the Integrated Care Board's (ICB) Medications Optimisation Committee.
At the Health and Care Partnership (HCP) & Primary Care Network (PCN), Michelle has been chair of patient facing groups and represented PCN Chairs on the West Kent Chairs’ Steering Group. She is a member of the Patient Access Panel; Advisor to Athena Primary Care Network (PCN) and represents Headcorn Patient Participation Group (PPG);
At Kent County Council (KCC), Michelle is co-chair of Adult Social Care & Health Quality Assurance Governance Board and the Culture, Performance & Finance Board. She is also a member of the People’s Panel & Technology Co-Production Group. Alongside the Innovation Challenge Team, where as a patient advisor, she has supported the work of the digital research collaborative; the Kent Surrey and Sussex Academic Health Science Network (KSS AHSN) and the Design and Learning Centre for Clinical and Social Innovation.
Having been a board member of the NHS Innovation Accelerator Programme she has worked to deliver the aims of creating the conditions and cultural change necessary, for proven innovations to be adopted faster and systematically throughout the NHS, and to deliver examples into practice for demonstrable patient and population benefit. To that end, she has contributed to the NHS Innovations Accelerator (NIA) development through the Core20Plus5 equality and diversity policy ambitions. Michelle seeks to build upon the health & care integration aims to see services that truly reflect citizen need and ambitions of their public services.
During the Covid-19 pandemic, Michelle actively supported the volunteer effort at a local and county level. Supporting through recruitment and personal protective equipment (PPE) production and distribution, the rollout of the vaccine & PPE programmes.
She is a firm supporter of national and international policy that reflects inclusivity of patient and public voice throughout every aspect of health and social care. From strategic planning and framing, to operational delivery and reform. Believing, only with continual active engagement, which ensures co-design with those receiving public services, will we truly be able to provide relevant and effective reforms that reflect our populations need. Supporting our innovators of today to realise those aspirations of tomorrow, is fundamental to that process.
ery Board, Demand Signalling Oversight Group & Advisory Group. Michelle is a member of the national Patient and Participation Groups (PPGs) Champion & Peer Trainers Groups.
At a county level and the Clinical Commissioning Group (CCG), Michelle sat on the Clinical Professional & Primary Care Boards; Patient & Public Advisory Group; Cancer Alliance Collaborative Group(s). She currently sits on the Integrated Care System (ICS) Kent & Medway Care Record Communications & Engagement & Technical Reference Oversight Group(s); My Care Record Steering Group and is chair of My Care Record - Citizen Engagement Group. She is a member of the Integrated Care Board's (ICB) Medications Optimisation Committee.
At the Health and Care Partnership (HCP) & Primary Care Network (PCN), Michelle chairs patient facing groups and represents PCN Chairs on the West Kent Chairs’ Steering Group. She is a member of the Patient Access Panel; Advisor to Athena Primary Care Network (PCN) and represents Headcorn Patient Participation Group (PPG);
At Kent County Council (KCC), Michelle is co-chair of Adult Social Care & Health Quality Assurance Governance Board and a member of the People’s Panel. Alongside the Innovation Challenge Team, where as a patient advisor, she has supported the work of the digital research collaborative; the Kent Surrey and Sussex Academic Health Science Network (KSS AHSN) and the Design and Learning Centre for Clinical and Social Innovation.
Having been a board member of the NHS Innovation Accelerator Programme she has worked to deliver the aims of creating the conditions and cultural change necessary, for proven innovations to be adopted faster and systematically throughout the NHS, and to deliver examples into practice for demonstrable patient and population benefit. To that end, she has contributed to the NHS Innovations Accelerator (NIA) development through the Core20Plus5 equality and diversity policy ambitions. Michelle seeks to build upon the health & care integration aims to see services that truly reflect citizen need and ambitions of their public services.
During the Covid-19 pandemic, Michelle actively supported the volunteer effort at a local and county level. Supporting through recruitment and personal protective equipment (PPE) production and distribution, the rollout of the vaccine & PPE programmes.
She is a firm supporter of national and international policy that reflects inclusivity of patient and public voice throughout every aspect of health and social care. From strategic planning and framing, to operational delivery and reform. Believing, only with continual active engagement, which ensures co-design with those receiving public services, will we truly be able to provide relevant and effective reforms that reflect our populations need. Supporting our innovators of today to realise those aspirations of tomorrow, is fundamental to that process.
